Effect of Treatment With Systane Ultra in Symptomatology and Visual Task Efficiency in Digital Device Users

NCT06505174 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 34

Last updated 2024-07-17

No results posted yet for this study

Summary

This study assessed the effect of one month of use of preservative-free artificial tears (Systane Ultra UD, Alcon) on symptomatology related to digital eye strain (DES), visual task performance, and tear film stability in visual display terminal users.

Conditions

  • Digital Eye Strain
  • Computer Vision Syndrome
  • OSDI

Interventions

OTHER

Hydroxypropyl Guar-based artificial tears four times per day

Use of hydroxypropyl Guar-based artificial tears four times per day

Sponsors & Collaborators

  • University of Valladolid

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-10
Primary Completion
2023-07-31
Completion
2023-07-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06505174 on ClinicalTrials.gov